Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PerkinElmer (NY: PKI )

N/A UNCHANGED
Last Price Updated: 7:00 PM EDT, May 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PerkinElmer

< Previous 1 2 3 4 5 6 Next >
PerkinElmer Offloads Applied, Food & Enterprise Services Businesses For ~$2.5B
Via Benzinga
PerkinElmer: Q2 Earnings Insights
  PerkinElmer (NYSE:PKI) reported its Q2 earnings results on Monday, August 1, 2022 at 06:12 AM. Here's what investors need to know about the announcement. 
Via Benzinga
New Mountain Capital Announces Intent to Acquire PerkinElmer’s Applied, Food and Enterprise Services Businesses for up to $2.45 Billion
From New Mountain Capital
Via Business Wire
PerkinElmer Announces Financial Results for the Second Quarter of 2022
From PerkinElmer, Inc.
Via Business Wire
What 4 Analyst Ratings Have To Say About PerkinElmer
Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter: 
Via Benzinga
PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
From PerkinElmer, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
Upgrades 
Via Benzinga
PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
From PerkinElmer, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022
Upgrades 
Via Benzinga
PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Launches BioQule NGS System to Automate Library Preparation
From PerkinElmer, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
Recap: PerkinElmer Q1 Earnings
PerkinElmer (NYSE:PKI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings PerkinElmer beat estimated earnings by... 
Via Benzinga
PerkinElmer Announces Financial Results for the First Quarter of 2022
From PerkinElmer, Inc.
Via Business Wire
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter. 
Via Benzinga
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was... 
Via Benzinga
PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification
From PerkinElmer, Inc.
Via Business Wire
Death Cross Looms Over PerkinElmer Investors
If history is any guide, there may be trouble ahead for shares of PerkinElmer (NYSE:PKI). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. 
Via Benzinga
7 Healthcare Stocks to Buy for the Long Term
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. 
Via InvestorPlace
Looking Into PerkinElmer's Return On Capital Employed
According to Benzinga Pro, during Q4, PerkinElmer (NYSE:PKI) earned $190.18 million, a 48.89% increase from the preceding quarter. PerkinElmer also posted a total of $1.36 billion... 
Via Benzinga
PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
From PerkinElmer, Inc.
Via Business Wire
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban... 
Via Benzinga
U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus
From PerkinElmer, Inc.
Via Business Wire
PerkinElmer (PKI) Q4 Earnings and Revenues Surpass Estimates
PerkinElmer, Inc. reported fourth-quarter 2021 adjusted earnings per share (EPS) of $2.56, which beat the Consensus Estimate of $2.15 per share by 19.1%. 
Via Talk Markets
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.